Sana Biotechnology Quarterly Balance Sheet
NASDAQ: SANAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Sana Biotechnology financial position
As of Jun 30, 2026, Sana Biotechnology reported total assets of $431.5 million, up 19.3% from a year earlier against total liabilities of $277.0 million. Shareholders' equity stood at $154.6 million, or 35.8% of assets. The company held $57.1 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 1.38, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Sana Biotechnology balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 57.07M | 83.80M | 71.87M | 103.36M | 71.27M | 96.13M | 127.57M | 127.00M | 134.96M | 177.05M | 133.52M | 168.45M |
| Short-Term Investments | 103.42M | 17.34M | 66.51M | 49.70M | 1.40M | 8.57M | 24.93M | 72.01M | 116.69M | 134.03M | 71.68M | 100.12M |
| Total Current Assets | 170.63M | 111.69M | 148.68M | 161.76M | 82.50M | 112.73M | 160.81M | 210.15M | 263.45M | 321.26M | 213.51M | 279.52M |
| Property, Plant & Equipment | 25.16M | 25.67M | 26.91M | 29.93M | 33.08M | 73.69M | 77.31M | 82.83M | 85.91M | 81.65M | 70.69M | 68.37M |
| Goodwill | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M | 140.63M |
| Intangible Assets | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M | 59.20M |
| Total Assets | 431.52M | 373.59M | 416.89M | 435.43M | 361.64M | 445.47M | 501.02M | 559.39M | 618.67M | 681.38M | 565.30M | 631.44M |
| Accounts Payable | 1.36M | 2.12M | 1.67M | 1.86M | 2.27M | 989.00K | 5.21M | 2.99M | 3.82M | 6.09M | 4.11M | 9.93M |
| Total Current Liabilities | 123.75M | 86.27M | 78.73M | 35.51M | 33.44M | 33.16M | 45.43M | 47.00M | 50.69M | 52.90M | 64.49M | 66.64M |
| Total Liabilities | 276.95M | 254.35M | 256.01M | 240.12M | 239.09M | 236.39M | 250.52M | 266.91M | 279.02M | 306.24M | 277.79M | 265.59M |
| Shareholders' Equity | 154.57M | 119.24M | 160.88M | 195.31M | 122.56M | 209.08M | 250.50M | 292.48M | 339.65M | 375.14M | 287.51M | 365.85M |
| Retained Earnings | -1.96B | -1.90B | -1.85B | -1.79B | -1.75B | -1.65B | -1.60B | -1.56B | -1.50B | -1.45B | -1.34B | -1.25B |
| Net Cash (Debt) | 160.49M | 101.14M | 138.38M | 153.05M | 72.67M | 104.70M | 152.50M | 199.01M | 251.64M | 311.08M | 205.19M | 268.57M |
| Shares Outstanding | 299.31M | 269.82M | 266.73M | 262.26M | 230.51M | 225.46M | 223.92M | 223.11M | 222.21M | 221.29M | 197.86M | 197.06M |
This table shows 12 quarterly periods of Sana Biotechnology's balance sheet, from Q2 2026 back to Q3 2023, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow SANA's reporting calendar. What is a balance sheet?